19hon MSN
Takeaways from the AP’s report on turmoil surrounding the FDA’s new fast-track drug program
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
19hon MSN
Legal questions swirl around FDA's new expedited drug program, including who should give sign off
The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...
1don MSN
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
The FDA expedited drug review activity in December 2025 includes six fast-tracked therapies and the first National ...
FDA delays drug reviews for two priority voucher drugs amid safety and efficacy concerns, extending timelines for Sanofi and Disc Medicine products.
Today, we discuss Trump’s lofty new health plan, see the FDA delay two drug reviews under the new voucher program, and more.
On September 29, 2025, the U.S. Food and Drug Administration (FDA) announced the expansion of its Early Alert program to include all medical devices. This expansion builds on a pilot program that ...
FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. (AP Photo/Jose Luis Magana, File) WASHINGTON (AP) — The Food and ...
On October 3, 2025, the U.S. Food and Drug Administration (FDA) unveiled a pilot prioritization program that provides for accelerated review of abbreviated new drug applications (ANDAs) for generic ...
SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family company Napo Pharmaceuticals (Napo) is providing the company’s novel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback